Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Volume this year...
12
Mar 01, 2012 05:44PM

The average daily volume increase also allows PTSC to do a good deal more share purchasing compared to recent past. If they have the cash we think they do, maxing out on the daily purchases while the pps is this low seems to be the logical and financially wise thing to do. If they aren't buying the max nu;mber of shares allowed, I hope there is one heck of a good explantion as to why. MY opinion only.

Opty

Share
New Message
Please login to post a reply